9TH - 10TH NOVEMBER

I am a speaker at
ABE Expo 2026

Kelly
Tobin
DermapenWorld Country Director
Sponsored · DermapenWorld
9th–10th November
Bristol Ashton Gate Stadium
Join me at the
ABE Expo
"Dermapenworld are delighted to be joining Hayley & the ABE EXPO team in September for their first conference in the Southwest.
We are so happy to be part of this event - the hard work & dedication from the team really shines! Exciting times ahead"
KELLY TOBIN - DERMAPENWORLD - COUNTRY DIRECTOR
Conference abstract · Sponsored session by DermaPenWorld
Kelly Tobin leads Dermapenworld in the UK as Country Director, working with clinics and practitioners using Dermapen and Dp Dermaceuticals. She has been shortlisted as a finalist for Best Company Representative at the Safety in Beauty Diamond Awards in each of the last four years.
As aesthetic technology continues to evolve, practitioners are increasingly looking for treatment approaches that combine innovation, precision and clinically informed skin regeneration.
This session explores the evolving role of multi-technology treatment platforms and how synergistic approaches can be incorporated into professional skin treatments. Kelly Tobin, Country Director for Dermapenworld in the UK, presents alongside Education Ambassador Andrew Hansford. Together they will explore the science and treatment philosophy behind Dermapenworld’s latest innovations, alongside the established Dermapen 4 platform.
They will consider how combining complementary technologies can support customised treatment protocols, enhance the delivery of active ingredients and create an environment designed to optimise skin health and regeneration.
Key learning outcomes
The Science
The principles behind technology-led skin regeneration and active ingredient delivery.
Synergy
How complementary technologies can be combined into customised treatment protocols.
Risk reduction
Best-practice protocols that lower complication risk.
Success
Integrating combinations thoughtfully into practice, with personalised planning and patient outcomes at the centre.
